Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1995 2
1997 2
1998 2
1999 1
2000 2
2001 1
2002 2
2003 1
2004 4
2005 8
2006 7
2007 2
2008 3
2009 2
2010 1
2011 1
2013 2
2014 6
2015 11
2016 10
2017 18
2018 18
2019 13
2020 15
2021 10
2022 8
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 31570470

135 results

Results by year

Filters applied: . Clear all
Page 1
Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up.
Georgakopoulos P, Roussou P, Matsakas E, Karavidas A, Anagnostopoulos N, Marinakis T, Galanopoulos A, Georgiakodis F, Zimeras S, Kyriakidis M, Ahimastos A. Georgakopoulos P, et al. Am J Hematol. 2010 Nov;85(11):894-6. doi: 10.1002/ajh.21840. Am J Hematol. 2010. PMID: 20872550 Free article. Clinical Trial.
Preventing cardiotoxicity in patients with breast cancer and lymphoma: protocol for a multicentre randomised controlled trial (PROACT).
Maier RH, Plummer C, Kasim AS, Akhter N, Ogundimu E, Maddox J, Graham J, Stewart M, Wardley A, Haney S, Vahabi S, Oxenham H, Humphreys A, Cresti N, Verrill M, Graham R, Chang L, Hancock HC, Austin D. Maier RH, et al. BMJ Open. 2022 Dec 30;12(12):e066252. doi: 10.1136/bmjopen-2022-066252. BMJ Open. 2022. PMID: 36585130 Free PMC article.
Prevention of doxorubicin-induced Cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial).
Carrasco R, Ramirez MC, Nes K, Schuster A, Aguayo R, Morales M, Ramos C, Hasson D, Sotomayor CG, Henriquez P, Cortés I, Erazo M, Salas C, Gormaz JG. Carrasco R, et al. Trials. 2020 Feb 4;21(1):137. doi: 10.1186/s13063-019-3963-6. Trials. 2020. PMID: 32019575 Free PMC article. Clinical Trial.
135 results